Mitra Mosharraf, PhD (she/her/hers)

CEO
Engimata

Mitra Mosharraf, PhD, MBA, CEO, Engimata Inc.
Dr. Mosharraf has over 20 years of experience in all stages of drug development and life cycle management of biotechnology drug products from companies such as Pfizer (Principal Scientist), HTD Biosystems (CSO) and Santen (Director, Product Development, Biologics). She received her MSc (Pharmacy) and PhD (Pharm Sci) from Uppsala University (Sweden) and executive MBA from Massachusetts Institute of Technology. She is an inventor on 4 patents, and author of 14 peer reviewed papers and 50 conference proceedings on importance of solid-state structure and molecular interactions for stability and efficacy of pharmaceutical drug products.

Poster(s):

• (M1530-02-08) A Versatile Room Temperature Stable Lipid Nanoparticle COVID-19 Protein-Based Vaccine
  Monday, October 23, 2023

  3:30 PM – 4:30 PM ET